11h
Medpage Today on MSNSGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney DiseaseThe dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.
To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...
Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...
Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...
I have discussed this before in an article a few years ago, about a specific condition, but I think it is time to review it ...
Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg ...
I have discussed this before in an article a few years ago, about a specific condition, but I think it is time to review it as a whole. All-encompassing public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results